1. Home
  2. AMH vs UTHR Comparison

AMH vs UTHR Comparison

Compare AMH & UTHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMH
  • UTHR
  • Stock Information
  • Founded
  • AMH 2012
  • UTHR 1996
  • Country
  • AMH United States
  • UTHR United States
  • Employees
  • AMH N/A
  • UTHR N/A
  • Industry
  • AMH Real Estate Investment Trusts
  • UTHR Biotechnology: Pharmaceutical Preparations
  • Sector
  • AMH Real Estate
  • UTHR Health Care
  • Exchange
  • AMH Nasdaq
  • UTHR Nasdaq
  • Market Cap
  • AMH 14.4B
  • UTHR 14.4B
  • IPO Year
  • AMH 2013
  • UTHR 1999
  • Fundamental
  • Price
  • AMH $36.17
  • UTHR $292.01
  • Analyst Decision
  • AMH Buy
  • UTHR Buy
  • Analyst Count
  • AMH 17
  • UTHR 13
  • Target Price
  • AMH $40.85
  • UTHR $383.08
  • AVG Volume (30 Days)
  • AMH 2.4M
  • UTHR 463.8K
  • Earning Date
  • AMH 07-31-2025
  • UTHR 07-30-2025
  • Dividend Yield
  • AMH 3.32%
  • UTHR N/A
  • EPS Growth
  • AMH 10.01
  • UTHR 18.86
  • EPS
  • AMH 1.08
  • UTHR 25.10
  • Revenue
  • AMH $1,764,418,000.00
  • UTHR $2,994,100,000.00
  • Revenue This Year
  • AMH $7.36
  • UTHR $14.58
  • Revenue Next Year
  • AMH $4.85
  • UTHR $6.34
  • P/E Ratio
  • AMH $33.45
  • UTHR $11.62
  • Revenue Growth
  • AMH 6.97
  • UTHR 19.84
  • 52 Week Low
  • AMH $31.68
  • UTHR $266.98
  • 52 Week High
  • AMH $41.41
  • UTHR $417.82
  • Technical
  • Relative Strength Index (RSI)
  • AMH 50.29
  • UTHR 46.41
  • Support Level
  • AMH $35.39
  • UTHR $291.72
  • Resistance Level
  • AMH $36.15
  • UTHR $302.52
  • Average True Range (ATR)
  • AMH 0.59
  • UTHR 6.65
  • MACD
  • AMH 0.11
  • UTHR 0.77
  • Stochastic Oscillator
  • AMH 73.45
  • UTHR 42.03

About AMH American Homes 4 Rent of Beneficial Interest

American Homes 4 Rent is a real estate investment trust focused on acquiring, operating, and leasing single-family homes as rental properties throughout the United States. The company's real estate portfolio is largely comprised of single-family properties in urban markets in the Southern and Midwestern regions of the U.S. American Homes 4 Rent's land holdings also represent a sizable percentage of its total assets in terms of value. The company derives the vast majority of its income in the form of rental revenue from single-family properties through short-term or annual leases. The firm's geographical markets include Dallas, Texas; Indianapolis, Indiana; Atlanta, Georgia; and Charlotte, North Carolina in terms of the number of properties in each.

About UTHR United Therapeutics Corporation

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.

Share on Social Networks: